Catalyst Wire Dossier Catalyst Wire Dossier

Allogeneic umbilical cord-derived hematopoietic and mesenchymal stem cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic umbilical cord-derived hematopoietic and mesenchymal stem cells, covering 2019-01-08 to 2019-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy [Phase 2]

See pricing